France – Vaccins – Achat de vaccins
AI summary
This tender concerns a framework agreement for the supply of vaccines to the Département de la Haute-Savoie. Seven lots cover routine childhood immunization vaccines including combined measles-mumps-rubella, tetanus-diphtheria-pertussis variants, hepatitis B, pneumococcal, meningococcal, and respiratory syncytial virus prevention products.
Pharmaceutical companies or authorized vaccine distributors with demonstrated experience supplying vaccines to public health authorities and compliance with French health and safety regulations.
Suppliers must be authorized to distribute pharmaceutical vaccines in France and meet EU and French regulatory standards for vaccine manufacturing, storage, and distribution. Documentation of product approvals and quality certifications is required.
Frequently asked questions
What is this tender about?
This tender concerns a framework agreement for the supply of vaccines to the Département de la Haute-Savoie. Seven lots cover routine childhood immunization vaccines including combined measles-mumps-rubella, tetanus-diphtheria-pertussis variants, hepatitis B, pneumococcal, meningococcal, and respiratory syncytial virus prevention products.
What are the requirements for suppliers?
Suppliers must be authorized to distribute pharmaceutical vaccines in France and meet EU and French regulatory standards for vaccine manufacturing, storage, and distribution. Documentation of product approvals and quality certifications is required.
What type of company should bid?
Pharmaceutical companies or authorized vaccine distributors with demonstrated experience supplying vaccines to public health authorities and compliance with French health and safety regulations.
Who is the buyer?
The buyer is Département de la Haute-Savoie.
What is the estimated value?
The estimated value is 366,172 EUR.
Accord-cadre à bons de commande mono-attributaire de fournitures avec minimum et maximum : Lot n°1 : vaccins combinés contre la rougeole, la rubéole et les oreillons - montant minimum annuel 375,00 euro(s) HT - montant maximum annuel 2 800,00 euro(s) HT Lot n°2 : Vaccins tétravalents contre diphtérie, tétanos, poliomyélite et coqueluche acellulaire - montant minimum annuel 214,00 euro(s) HT - montant maximum annuel 1 131,00 euro(s) HT Lot n°3 : Vaccins contre l'hépatite B - dosage enfant - montant minimum annuel 267,00 euro(s) HT - montant maximum annuel 729,00 euro(s) HT Lot n°4 : Vaccins hexavalents contre diphtérie, tétanos, poliomyélite, coqueluche acellulaire, haemophilus influenzae de type B conjugué, et hépatite B - montant minimum annuel 2555,00 euro(s) HT - montant maximum annuel 20 640,00 euro(s) HT Lot n°5 : Vaccin pneumococcique polyosidique conjugué (15-valents absorbés) - montant minimum annuel 932,00 euro(s) HT - montant maximum annuel 5 739,00 euro(s) HT Lot n°6 : Vaccin méningococcique conjugué des groupes A, C, W135 et Y - montant minimum annuel 3 300,00 euro(s) HT - montant maximum annuel 12 288,00 euro(s) HT Lot n°7 : Anticorps monoclonal en prévention des infections à VRS - montant minimum annuel 8 011,00 euro(s) HT - montant maximum annuel 48 216,00 euro(s) HT
Documents not listed
Lot n°1 : vaccins combinés contre la rougeole, la rubéole et les oreillons
Vaccins combinés contre la rougeole, la rubéole et les oreillons
Lot n°2 : Vaccins tétravalents contre diphtérie, tétanos, poliomyélite et coqueluche acellulaire
Vaccins tétravalents contre diphtérie, tétanos, poliomyélite et coqueluche acellulaire
Lot n°3 : Vaccins contre l'hépatite B - dosage enfant
Vaccins contre l'hépatite B - dosage enfant
Lot n°4 : Vaccins hexavalents contre diphtérie, tétanos, poliomyélite, coqueluche acellulaire, haemophilus influenzae de type B conjugué, et hépatite B
Vaccins hexavalents contre diphtérie, tétanos, poliomyélite, coqueluche acellulaire, haemophilus influenzae de type B conjugué, et hépatite B
Lot n°5 : Vaccin pneumococcique polyosidique conjugué (15-valents absorbés)
Vaccin pneumococcique polyosidique conjugué (15-valents absorbés)
Lot n°6 : Vaccin méningococcique conjugué des groupes A, C, W135 et Y
Vaccin méningococcique conjugué des groupes A, C, W135 et Y
Lot n°7 : Anticorps monoclonal en prévention des infections à VRS
Anticorps monoclonal en prévention des infections à VRS
- QualityValeur technique60%
- PricePrix40%
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…